{
    "Trade/Device Name(s)": [
        "Polymed Therapeutics Fastep Dipstick Drugs of Abuse Screen Device",
        "Polymed Therapeutics Fastep Dipcard Drugs of Abuse Screen Device"
    ],
    "Submitter Information": "Polymed Therapeutics, Inc.",
    "510(k) Number": "K121065",
    "Predicate Device Reference 510(k) Number(s)": [
        "K011673",
        "K012300",
        "K010841",
        "K022589",
        "K011353",
        "K011730",
        "K003557"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LDJ",
        "DIO",
        "LCM",
        "DNK",
        "DKZ",
        "JXM",
        "DJC"
    ],
    "Summary Letter Date": "May 20, 2013",
    "Summary Letter Received Date": "May 23, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3870",
        "21CFR862.3250",
        "21CFR862.3640",
        "21CFR862.3100",
        "21CFR862.3170",
        "21CFR862.3610"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Benzodiazepines",
        "Cocaine",
        "Marijuana",
        "Morphine",
        "Phencyclidine",
        "MDMA",
        "Ecstasy"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Colloidal gold based chromatographic immunoassay",
        "Lateral flow chromatographic immunoassay"
    ],
    "Methodologies": [
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Dipstick",
        "Dipcard"
    ],
    "Document Summary": "FDA 510(k) summary for Polymed Therapeutics Fastep Dipstick and Dipcard Drugs of Abuse Screen Device for qualitative detection of multiple drugs in urine using immunochromatographic assay.",
    "Indications for Use Summary": "Rapid chromatographic immunoassay for the qualitative and simultaneous detection of up to seven drugs (amphetamines, benzodiazepines, cocaine, marijuana, morphine, phencyclidine, and MDMA) in human urine for prescription use in central laboratories; provides preliminary results requiring confirmatory testing.",
    "fda_folder": "Toxicology"
}